Traws Pharma, Inc. TRAW
0.24 USD +0.02 (+8.84%)
Nov 11, 2026, 1:51 PM EST
0.235 Day range 0.2479
0.22 52-week range 3.23
- YTD
- -78.33%
- 1 year
- -87.04%
News
benzinga.com Traws Pharma Enters $50M Committed Equity Purchase Agreement With Roth Principal Investments; May Issue And Sell Up To 135,135,135 Shares Of Common Stock Traws Pharma, Inc.Up to 135,135,135 Shares of Common StockThis prospectus relates to the resale by Roth Principal Investments, LLC, a Delaware limited liability company ("Roth Principal Investments"…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 27.1% to $0.31 during Monday's after-market session. The market value of their outstanding shares is at $1.4 million. Chemomab Therapeutics…- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Apimeds Pharmaceuticals (AMEX:APUS) shares rose 23.4% to $6.07 during Friday's pre-market session. The market value of their outstanding shares is at $7.4 million. Firefly Neuroscience…
benzinga.com Why INLIF Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket INLIF shares jumped 78% after H1 FY26 revenue rose 26%, gross profit surged 159% and net income turned positive; other premarket movers varied.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Decoy Therapeutics (NASDAQ:DCOY) shares rose 84.0% to $4.71 during Tuesday's pre-market session. The company's market cap stands at $1.6 million. Greenland Mines (NASDAQ:GRML) shares rose…
benzinga.com HC Wainwright & Co. Reiterates Neutral on Traws Pharma, Maintains $1 Price Target HC Wainwright & Co. analyst Brandon Folkes reiterates Traws Pharma (NASDAQ:TRAW) with a Neutral and maintains $1 price target.- benzinga.com Traws Pharma Q2 EPS $(0.16) Beats $(0.34) Estimate Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.34) by 51.52 percent. This is a 45.45 percent decrease over losses of…
benzinga.com Traws PharmaFiles Prospectus For Mixed Shelf Offering Of Up To ~$139.2M Traws Pharma, Inc. $139,185,641.25 Common StockPreferred StockDebt SecuritiesWarrantsUnits This prospectus covers our offer and sale from time to time of any combination of common stock, preferred…- benzinga.com Traws Pharma Announces That An Updated Toxicology Data Package Is Being Developed In Response To The UK MHRA's Information Requirements For Planned Testing Of Tivoxavir Marboxil In A Phase 2a Human Influenza Challenge Study The updated data package is expected to be resubmitted to MHRA during the third quarter of 2026. "Based upon recent feedback and further guidance from the MHRA, we believe our updated data package…
benzinga.com This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday Wall Street analysts updated ratings for CURB, INTU, ENGN. See their outlooks and targets at Benzinga's analyst ratings page.- benzinga.com HC Wainwright & Co. Downgrades Traws Pharma to Neutral, Announces $1 Price Target HC Wainwright & Co. analyst Brandon Folkes downgrades Traws Pharma (NASDAQ:TRAW) from Buy to Neutral and announces $1 price target.
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com Traws Pharma Stock Falls As UK Regulator Delays Key Flu Study Traws Pharma shares fell after UK regulators deferred a planned influenza challenge study for tivoxavir marboxil, delaying clinical development.- benzinga.com 10 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Bandwidth, Traws Pharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session Dow futures up 400 points; Bandwidth Inc (BAND) falls after $275M offering; other stocks declining in pre-market trading.
benzinga.com Why Tower Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket Tower Semiconductor (TSEM) jumped 4.7% in pre-market trading after announcing a multi-year supply agreement and resolving IP disputes. Other gainers include VS Media Holdings (VSME), Freecast Inc…
benzinga.com U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
benzinga.com Traws Pharma Announces Advancement Of Its Novel Proprietary Broad-Spectrum Combination Anti-Viral Agent With Potential Utility Against Hantavirus, Ebola and Lassa Traws Pharma, Inc. (NASDAQ:TRAW), a clinical-stage biopharmaceutical company developing novel therapies for critical global viral threats, today announced the advancement of a novel proprietary…- benzinga.com HC Wainwright & Co. Reiterates Buy on Traws Pharma, Maintains $8 Price Target HC Wainwright & Co. analyst Brandon Folkes reiterates Traws Pharma (NASDAQ:TRAW) with a Buy and maintains $8 price target.
benzinga.com Earnings Scheduled For May 15, 2026 - benzinga.com Traws Pharma Q1 EPS $(0.53) Beats $(0.56) Estimate Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.56) by 5.36 percent. This is a 66.46 percent increase over losses of $(1.58)…
benzinga.com Chuck Schumer Blasts Trump, Elon Musk For Firing CDC And Port Health Workers As Hantavirus Scare Grips The World Hantavirus outbreak on a cruise ship sparks alarm as Schumer blames CDC cuts, warning weakened disease surveillance and calling for urgent reforms.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com Traws Pharma Gains After Hantavirus Drug Development Update Amid Cruise Ship Outbreak Traws Pharma shares jump after the company advanced hantavirus antiviral candidates amid global monitoring of a cruise ship outbreak.- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Traws Pharma Announces Plans To Advance Potential Clinical Candidates For The Treatment Of Hantavirus Infection Traws Pharma, Inc. (NASDAQ:TRAW) ("Traws Pharma", "Traws" or "the Company"), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com This Linde Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session - benzinga.com Earnings Scheduled For August 14, 2025
benzinga.com Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket - benzinga.com Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November
- benzinga.com Crude Oil Gains 1%; Chicago PMI Falls In December
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com Gold Moves Lower, Rumble Shares Jump
- benzinga.com Nasdaq Surges Over 100 Points, US Durable Goods Orders Decline In November